Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,862,000 | 241,000 | 167,000 | 2,811,000 | 1,831,000 |
| Cost of Goods | 514,000 | 115,000 | 96,000 | 929,000 | 2,241,000 |
| Gross Profit | 1,348,000 | 126,000 | 71,000 | 1,882,000 | -410,000 |
| Operating Expenses | 1,418,000 | 1,489,000 | 1,337,000 | 1,876,000 | 1,602,000 |
| Operating Income | -70,000 | -1,363,000 | -1,266,000 | 6,000 | -2,012,000 |
| Other Income | 91,000 | 84,000 | 101,000 | 64,000 | 54,000 |
| Pre-tax Income | 21,000 | -1,279,000 | -1,165,000 | 70,000 | -1,958,000 |
| Income Tax | 8,000 | N/A | 10,000 | -147,000 | 1,672,000 |
| Net Income Continuous | 13,000 | -1,279,000 | -1,175,000 | 217,000 | -3,630,000 |
| Net Income | $13,000 | $-1,279,000 | $-1,175,000 | $217,000 | $-3,630,000 |
| EPS Basic Total Ops | 0.03 | -3.33 | -3.07 | 0.62 | -9.53 |
| EPS Basic Continuous Ops | 0.03 | -3.33 | -3.08 | 0.60 | -9.53 |
| EPS Diluted Total Ops | 0.03 | -3.33 | -3.07 | 0.63 | -9.53 |
| EPS Diluted Continuous Ops | 0.03 | -3.33 | -3.08 | 0.61 | -9.53 |
| EPS Diluted Before Non-Recurring Items | 0.03 | -3.33 | -3.07 | 0.55 | -1.39 |
| EBITDA(a) | $-39,000 | $-1,350,000 | $-1,257,000 | $188,000 | $-1,775,000 |